ACRS - Aclaris Therape Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 XLF (-0.72%) F (-0.09%) AAPL (1.61%) APPS (9.55%) BTCUSD (%) FUTU (0.99%) NDAQ (-0.7%) REGI (3.59%) SPWR (7.84%) XSPA (8.08%) EVGN (-1.77%) ETSY (0.5%) ETHUSD (%) ENDP (1.77%) ELY (1.19%) DQ (2.44%) DGLY (2.32%) DFS (-2.09%) DAR (-1.25%) DAL (-1.65%) CVET (-1.85%) CRSP (1.84%) COWN (-1.95%) CELH (2.39%) BIOL (0%)

Recommendation

Service : FEAT. ANDRE 3000 | Trader : JOHN KROLIKOWSKI JR | Trade Date : 11/13/20

$ACRS - Aclaris Therapeutics

Buy Long

Trade

86.17 %

Target

$3.76

Issue Price

$7.00

Target Price

11/13/21

Target Date

$1.99

Stop Loss

Trade Closed - WINNER

Hit Target Price

Reason

75.53 %

P/L %

$6.60

Close Price

39

Days Held

12/22/20

Closed Date

To view trade details and get more recommendations from this trader Subscribe

ACRS - Aclaris Therapeutics

$18.22 0.18[1%]

15 mins delayed data

People also watch : OPHLY | ONCX | OMER

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$18.22	Open
Volume	6.8K	Market Cap	774.26M
Yield		Last Dividend

Day

52 Week

The Daily Biotech Pulse: Addex Jumps On ...	01/21/21
Here???s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 20) 1...

General Motors, AMC, Roku: 5 Top Stock G...	01/19/21
General Motors, AMC Entertainment, Tencent Music, Aclaris Therapeutics and Roku are rising Tuesday.

Aclaris Therapeutics stock more than tri...	01/19/21
Shares of Aclaris Therapeutics Inc. undefined skyrocketed more than 200% toward a 2 1/2-year high, on massive volume, in midday trading Tuesday, after...

ACRS Stock Alert: Why Aclaris Therapeuti...	01/19/21
Aclaris Therapeutics (ACRS) stock is soaring higher on Tuesday after revealing results from a recent Phase 2a clinical trial.

Is Aclaris Therapeutics a Stock to Buy A...	01/19/21
No summary available.

Why Aclaris, Tenax, Gritstone, Merus, Mi...	01/19/21
A slew of biopharma stocks are making big moves Tuesday on the back of clinical trial readouts as well announcements regarding M&A and tie-ups. Merus,...

The Daily Biotech Pulse: FDA Nod For Amp...	12/29/20
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 28) Acl...

Thinking about buying stock in MacroGeni...	12/17/20
NEW YORK, Dec. 17, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MGNX, ABUS, RIOT, ACRS, and MYOV. To see how Investors...

Aclaris Therapeutics to Participate in t...	11/16/20
WAYNE, Pa., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on develop...

Short Interest in Aclaris Therapeutics I...	10/22/20
Aclaris Therapeutics Inc (NASDAQ:ACRS) saw a large increase in short interest during the month of September. As of September 30th, there was short int...

The Daily Biotech Pulse: Gilead, Lilly C...	10/08/20
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-Week Highs Oct. 7) 10X ...

The Daily Biotech Pulse: Bristol-Myers S...	10/07/20
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) 10X ...

The Daily Biotech Pulse: Pfizer, BioNTec...	10/06/20
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) 10X ...

Aclaris Therapeutics to Present at Upcom...	09/01/20
WAYNE, Pa., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on???

Aclaris Therapeutics Reports Second Quar...	08/07/20
??? First Subject Dosed in Phase 2a Trial of ATI-450, an Investigational Oral MK2 Inhibitor, as a Potential Treatment for Moderate to Severe Rheumatoi...

Will Aclaris Therapeutics (ACRS) Report ...	08/06/20
Aclaris (ACRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with t...

Seborrhea Pipeline Research Monitor, 202...	07/24/20
DUBLIN--(BUSINESS WIRE)--The "Seborrhea Pipeline Research Monitor, 2020 - Drugs, Companies, Clinical Trials, R&D Pipeline Updates, Status and Outlook"...

The Daily Biotech Pulse: Opko Wins CDC C...	07/21/20
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Abb...

Aclaris Rips Higher Following FDA Approv...	06/17/20
Shares of micro-cap biopharma Aclaris Therapeutics Inc (NASDAQ: ACRS ) were rallying Wednesday after the FDA gave its blessing for the company's inves...

Thinking about buying stock in Biocept, ...	06/17/20
NEW YORK, June 17, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BIOC, TOPS, ACRS, SHIP, and INWK. To see how Investors...

Will Aclaris Therapeutics Continue to Su...	05/12/20
As of late, it has definitely been a great time to be an investor Aclaris Therapeutics

All You Need to Know About Aclaris (ACRS...	05/08/20
Aclaris (ACRS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

The Daily Biotech Pulse: Mylan Ramps Up ...	03/20/20
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) ...

The Daily Biotech Pulse: Pfizer's Eczema...	03/19/20
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18)...

The Daily Biotech Pulse: Positive Data R...	01/10/20
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 9) A...

Shareholder Alert: Robbins LLP Announces...	11/21/19
SAN DIEGO & WAYNE, Pa.--(BUSINESS WIRE)---- $ACRS #ClassAction--Shareholder rights law firm Robbins LLP announces that a purchaser of Aclaris Therapeu...

Aclaris Therapeutics Inc (NASDAQ:ACRS) S...	11/13/19
Aclaris Therapeutics Inc (NASDAQ:ACRS) saw a large increase in short interest in October. As of October 31st, there was short interest totalling 4,260...

SDRL, ROKU among top premarket gainers	10/11/19
Synthesis Energy Systems SES +88% on acquiring Australian Future Energy in all-stock deal. Aclaris Therapeutics ACRS +24% on divesting Rhofade for up ...

Aclaris Therapeutics Announces Divestitu...	10/10/19
Aclaris Therapeutics, Inc. (ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory diseases, today announced it has divested ...

The Daily Biotech Pulse: FDA Approves Cl...	10/09/19
The following is a roundup of top developments in the biotech space over the last 24 hours. None of the NYSE or Nasdaq-listed biotech stocks hit 52-we...

ANALYST RATINGS

1 analyst ratings (Last 3 months)

100.00 %

Strong Buy + Buy

Price Target (PT)

Strong Buy rating	01/20/21
SVB Leerink maintains Outperform rating and raises Price Target from $4.50 to $21.00

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $ACRS

Service Name	Trader	% Success
FEAT. ANDRE 3000	JOHN KROLIKOWSKI JR	89.00 %	Subscribe
FEAT. PIMP C	JOHN KROLIKOWSKI JR	88.00 %	Follow
FEAT. KENNY G	JOHN KROLIKOWSKI JR	48.00 %	Follow
Biotechnology	Robert Gadimian	26.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.